Sandu Pharmaceuticals Ltd — Updates, 28-05-2025: Company Update

Sandu Pharmaceuticals has announced a board meeting in which it approved the reclassification request of Akshath Finvest and Properties Private Limited from the promoter group to the public category. Holding 5.12% of equity shares, Akshath Finvest confirmed that neither it nor its promoters or directors have any role in the company’s management or special rights. This move relieves the entity from promoter-related compliance burdens, reflecting its non-involvement in company operations. The reclassification is subject to the stock exchange’s approval.